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ABSTRACT
Background: To evaluate the ability of community-
based exercise programmes to facilitate public
participation in exercise and hence improved
cardiovascular health, we assessed the respective
impacts of: a continuously monitored exercise
programme based within our university (study 1); a
Valleys Regional Park-facilitated community-based
outdoor exercise programme (study 2); a Wales
National Exercise Referral Scheme-delivered exercise-
referral programme (study 3).
Methods: Biomolecular (monocytic PPARγ target
gene expression), vascular haemodynamic (central/
peripheral blood pressure, arterial stiffness), clinical
(insulin sensitivity, blood lipids) and anthropometric
(body mass index, waist circumference, heart rate)
parameters were investigated using RT-PCR,
applanation tonometry, chemical analysis and standard
anthropometric techniques.
Results: In studies 1–3, 22/28, 32/65 and 11/14
participants adhered to their respective exercise
programmes, and underwent significant increases in
physical activity levels. Importantly, beneficial effects
similar to those seen in our previous studies (eg,
modulations in expression of monocytic PPARγ target
genes, decreases in blood pressure/arterial stiffness,
improvements in blood lipids/insulin sensitivity) were
observed (albeit to slightly differing extents) only in
participants who adhered to their respective exercise
programmes. While study 1 achieved more intense
exercise and more pronounced beneficial effects,
significant cardiovascular risk-lowering health benefits
related to biomolecular markers, blood pressure,
arterial stiffness and blood lipids were achieved via
community/referral-based delivery modes in studies 2
and 3.
Conclusions: Because cardiovascular health benefits
were observed in all 3 studies, we conclude that the
majority of benefits previously reported in laboratory-
based studies can also be achieved in community-
based/exercise-referral settings. These findings may be
of use in guiding policymakers with regard to
introduction and/or continued implementation of
community/referral-based exercise programmes.
INTRODUCTION
Physical activity is a major factor in prevent-
ing/delaying onset of cardiovascular disease
(CVD), and in increasing life expectancy and
quality of life.1 However, only 30–60% of UK
adults partake in recommended levels of
physical activity.2–4 Therefore, there is an
urgent need to implement accessible exer-
cise programmes that can facilitate increased
public participation in exercise. Similarly,
where such programmes exist, there is a
need to evaluate these programmes with
regard to their abilities to alleviate CVD risk,
and hence evaluate the beneﬁts that such
initiatives may bring to patients/participants,
and more broadly to society as a whole.
Summary of new findings
▪ Cardiovascular health benefits (in line with those
seen in our previous investigations) observed in
an in-house continuously monitored exercise
programme that took place in a University exer-
cise physiology laboratory were also observed in:
(1) a community-based outdoor exercise pro-
gramme; (2) a clinically associated
exercise-referral programme.
▪ Exercise-associated changes in a group of easily
measured ‘biomarkers’ (eg, monocytic expres-
sion of PPARγ target genes) were associated
with exercise-related improvements in a series of
clinical parameters relevant to cardiovascular
disease (CVD) risk. Thus, exercise-triggered cell
signalling events which can be detected in
monocytes may contribute to mechanisms that
underpin systemic CVD risk-lowering health
benefits.
▪ Similar exercise-associated impacts (in terms of
both biomarkers and health benefits) were
observed in (1) participants with overt
CVD-related conditions; and (2) healthy but sed-
entary participants.
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We and others have reported that during exercise,
certain signals are released from skeletal muscle into the
circulation;5–14 reviewed in refs. 15 and 16. Thus, single
exercise bouts have acute impacts on levels of blood-
borne signals such as activators of the ligand-activated
transcription factor PPARγ,8 10 and on expression within
circulating monocytes of target genes for these
signals.5 8–10 Similarly, sustained changes in monocytic
expression patterns of these target genes are seen in par-
ticipants who have undergone exercise programmes
involving regular exercise over periods of >8 weeks.7 8 10 11
We have identiﬁed associations between such
exercise-associated signalling effects and clinical para-
meters relevant to CVD risk: exercise-associated activation
of PPARγ signalling correlates with improvements in
insulin sensitivity,10 increased high-density lipoprotein
(HDL) cholesterol,11 reduced arterial stiffness7 and
reduced fasting plasma glucose.10 Thus, our previous
studies have established a group of easily measured ‘bio-
markers’ that may be used to evaluate the ability of exer-
cise programmes to achieve CVD risk-lowering clinical
outcomes.5–14
However, because our previous studies invariably
involved participants undertaking continuously moni-
tored sessions in University laboratories under the con-
stant supervision of researchers, we wished to carry out
translational research evaluating whether the beneﬁcial
effects seen in our previous laboratory-based studies can
also be demonstrated in exercise-referral/community-
based interventions. In Wales (where the current study
was based), the Valleys Regional Park (VRP) facilitates
provision of community-based outdoor walking pro-
grammes to residents of the South Wales Valleys, while
the Wales National Exercise Referral Scheme (NERS)
standardises exercise referral opportunities across all
Welsh Local Authorities/Health Boards.17 However,
although 68% of NERS participants are referred for
CVD-related conditions,18 previous evaluations of NERS
exercise programmes have been limited to adherence,
quality of life, cost-effectiveness and mental health,18–21
while evaluation of VRP programmes has not been
undertaken at all.
Therefore, to test the hypothesis that exercise-referral/
community-based initiatives are a viable means of making
exercise-associated health beneﬁts accessible to a broad
cross-section of the population, the current study aimed to
evaluate the respective impacts of: (1) an in-house con-
tinuously monitored exercise programme; (2) a
VRP-facilitated community-based outdoor exercise pro-
gramme; (3) a NERS-delivered exercise-referral pro-
gramme, with regard to the range of biomolecular,
vascular haemodynamic, clinical and anthropometric
parameters used in our previous studies.5–14
MATERIALS/METHODS
Study 1: Twenty-eight healthy participants (age 44.6±11.4
years; 89% females/11% males; 93% Caucasian), deemed
to lead sedentary lifestyles following completion of
International Physical Activity Questionnaires (IPAQs),
were recruited from staff/students of Cardiff Metropolitan
University. Exclusion criteria were a history of cardiovascu-
lar/metabolic disorders, a physically active lifestyle (ie,
taking part in structured exercise three times or more per
week), pregnancy or taking CV-acting medications.
Initially, participants’ maximal oxygen consumption
(VO2max) was estimated using Rockport ﬁtness walking
tests22; participants then completed 3×45 min monitored
treadmill-walking sessions each week for a total of 24 ses-
sions (10 000 steps per session). Throughout the 8-week
programme, heart rate was monitored, and the speed at
which participants walked was adjusted according to
changes identiﬁed in their heart rate (ie, pace was
increased as heart rate decreased/plateaued) in order to
maintain a constant ‘moderate’ intensity (66.63±1.37% of
maximal heart rate (deﬁned as {220−participant age}23),
or approximately 60% VO2max).
Measurements were taken at baseline (week 0) and on
completion (week 8) of the programme. Consultations
took place under fasting conditions (no food consump-
tion on the day of testing); participants had not con-
sumed alcohol/caffeine or carried out any strenuous
exercise in the previous 24 h. Participants completed a
lifestyle/dietary questionnaire during each consultation;
no signiﬁcant changes in lifestyle/diet were observed
over the period of the intervention.
Anthropometric measurements: Body mass, body mass index
(BMI), waist circumference and heart rate were measured
using standard protocols. Peripheral blood pressure (BP)
was measured on the non-dominant arm, according to
European Society of Hypertension guidelines.24
Collection of blood samples: Whole blood was obtained by
venepuncture of the antecubital vein and collected in
EDTA and serum separator vacuum tubes for collection
of leucocytes and serum samples, respectively, as previ-
ously described.11 Monocytes were obtained from leuco-
cyte samples using commercial monocyte-isolation
columns (QuadroMACS separator units, LS columns
and CD14 MicroBeads (Miltenyi Biotec, Bisley, UK))
according to the manufacturers’ instructions. RNA was
obtained from monocyte samples, converted to cDNA
and used in Fast-SYBRGreen (Applied Biosystems,
Paisley, UK) or Taqman Primetime (Integrated DNA
Technologies Inc, Iowa, USA) PCR-based gene expres-
sion assays as previously described.7 Oligonucleotide
primers (Sigma, Poole, UK) were: ATP-Binding Cassette
protein A1 (ABCA1): F: 5’ GCACTGAGGAAGATGCTG
AAA 3’; R: 5’ AGTTCCTGGAAGGTCTTGTTCA 3’;
cluster of differentiation isoform-36 (CD36): F: 5’ GG
AAGTGATGATGAACAGCAGC 3’; R: 5’ GAGACTGTG
TTGTCCTCAGCGT 3’; matrix metalloproteinase-9
(MMP-9): ‘Taqman Primetime’ code Hs00234579_m1;
β-actin (‘housekeeper gene’ #1): ‘Taqman Primetime’
code 4310881E-1404039; GAPDH (‘housekeeper gene’
#2): F: 5‘CATTGACCTCAACTACATG 3’; R: 5’
TCTCCATGGTGGTGAAGAC 3’.
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Analysis of serum samples: Serum fasting insulin levels
were determined using an Invitrogen Insulin Assay Kit
(both Invitrogen Ltd, Paisley, UK). An iLab V.300 Plus
clinical chemistry analyser (Instrumentation Laborator-
ies UK Ltd, Warrington, UK) was used to quantify
fasting glucose, total and HDL-cholesterol, and triglycer-
ides, within serum samples. Serum low-density lipopro-
tein (LDL) levels were calculated using the Friedewald
equation.25 Insulin sensitivity was quantiﬁed using the
homeostatic model assessment formula.26
Study 2: Sixty-ﬁve participants (age 44.5±2.5 years; 85%
females/15% males; 98% Caucasian) who had expressed
an interest (independently of this study) in joining
community-based twice-weekly outdoor walking groups
set up as afﬁliates of VRP were recruited. Inclusion/
exclusion criteria, ethical considerations, anthropomet-
ric measurements, blood sample collection, serum ana-
lysis, RNA extraction and PCR-based gene expression
assays were all as for study 1. As for study 1, participants
completed a lifestyle/dietary questionnaire during each
consultation, and no signiﬁcant changes in lifestyle/diet
were observed over the period of the intervention.
However, the following aspects of study 2 were distinct in
nature from study 1.
Green exercise
The study was carried out in the South Wales Valleys, an
area of high social and economic deprivation, low phys-
ical activity levels and some of the worst health statistics
in Europe.27 Community-based green exercise walking
group initiatives (as facilitated by VRP in the present
case) are being employed as a method of combating low
physical activity and poor health in the South Wales
Valleys, by engaging people with exercising in their local
area/environment. The walks took place in rural/coun-
tryside settings, and as such constituted ‘green exercise’
(ie, any exercise that takes place in a relatively natural
setting28). Physical activity levels undertaken during
each walk were quantiﬁed using accelerometer arm
bands (BodyMedia SenseWear, Pennsylvania, USA).
Vascular haemodynamic measurements
Augmentation Index (AIx, an indirect measure of sys-
temic arterial stiffness) and aortic pulse wave velocity
(aPWV, the ‘gold standard’ measure of large artery stiff-
ness) were recorded non-invasively using applanation
tonometry (SphygmoCor, Atcor Medical, Sydney,
Australia).29 Recording the radial pulse wave enabled
reconstruction and pulse wave analysis of the central
aortic pulse waveform (and hence, determination of
central systolic BP and diastolic BP) using a generalised
transfer function. aPWV was measured as the velocity of
the pulse wave as it travels along the aorta, as previously
described.29 Determination of path length was calcu-
lated using a tape measure between the suprasternal
notch and both carotid and femoral artery sites. aPWV
data were normalised to the mean arterial pressure
(mean arterial pressure-adjusted carotid-femoral aPWV),
while AIx data were normalised to heart rate (AIx at
HR75 bpm).
Study 3: Fourteen participants (age 56.0±3.9 years;
50% females/50% males; 100% Caucasian), who had
been referred to 16-week leisure centre-based NERS
exercise programmes, were recruited (NB: to aid com-
parison with studies 1 and 2, sampling was carried out at
weeks 0 and 8 of this programme). This cohort’s age is
in line with previous NERS evaluations (age 52±15
years18), which suggests that the cohort was representa-
tive of NERS participants as a whole. The exercise pro-
gramme comprised twice-weekly 35 min group exercise
sessions (walking-based gym sessions; NERS patients
only) that were professionally supervised by a NERS
‘exercise professional’.19
Inclusion and exclusion criteria, anthropometric mea-
surements, blood sample collection, serum analysis,
RNA extraction and PCR-based gene expression assays
were as for studies 1 and 2, with the exception of the
study’s main inclusion criterion: participants had to have
been referred by their general practitioner (GP) to
NERS for conditions that had raised CVD risk (eg, ‘pre-
diabetes’ diagnoses (impaired glucose tolerance and/or
increased fasting glucose), obesity, hypertension). As for
study 1, participants completed a lifestyle/dietary ques-
tionnaire during each consultation; no signiﬁcant
changes in lifestyle/diet were observed over the period
of the intervention. Finally, measurement of physical
activity levels and vascular haemodynamics was carried
out as for study 2.
Ethical considerations
In all three cases, the studies conformed to the princi-
ples outlined in the Declaration of Helsinki: all partici-
pants completed informed consent forms, and ethical
approval was granted by either the Cardiff Metropolitan
University faculty of Health Science Research Ethics
Committee or the UK National Health Service (NHS)
Integrated Research Application System.
Statistical analysis
All data were expressed as mean±SEM; paired t tests and
analyses of variance were used to compare differences
between two-sample and multiple data sets, respectively.
Correlation analyses (using Pearson’s method) were also
carried out, with ‘Δ changes’ (ie, differences between
measurements taken pre-exercise at weeks 0 and 8 of the
intervention) used as source data for these analyses.
Statistical analyses were performed using Minitab16
and/or SPSS software, with results deemed signiﬁcant at
p<0.05.
RESULTS
Levels of physical activity/adherence: Study 1’s exercise pro-
gramme was explicitly deﬁned as 30 000 steps/week,
undertaken as 3×45 min sessions. Adherence was
ensured by continuous monitoring by researchers;
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participants who failed to attend or complete a session
were excluded from the remainder of the study. Of the
original 28 participants, 6 were excluded for this reason;
data from only the remaining 22 participants are
included in this manuscript.
For study 2, registers of attendance, taken throughout
the programme to determine the adherence of each
participant, demonstrated that not all participants
attended all walks. Adherence to exercise programmes is
commonly deﬁned as attendance of at least 70% of ses-
sions;30 based on this, the cohort was split into two sub-
groups: those who adhered to the programme (n=32),
and those who did not adhere (n=33). Accelerometer
data identiﬁed that participants within the adherent
group were physically active for 34±3 min per session
(during which the intensity of the exercise undertaken
was 3.58±0.06 metabolic equivalent of tasks (METs),
which corresponds to a moderate intensity23), and
achieved 8684±236 steps/week in addition to their
normal lifestyles (p<0.001, paired t test vs week 0). The
non-adherent group’s physical activity levels remained
constant, while the adherent group’s physical activity
levels underwent a signiﬁcant increase of 296±29 IPAQ
MET-mins/week (p<0.001, paired t test vs week 0).
For study 3, registers showed that 11/14 participants
attended their prescribed exercise sessions (and also their
consultation sessions with researchers); the 3 participants
who did not attend were excluded from the remainder of
the study. Accelerometer data demonstrated that partici-
pants achieved 3486±469 additional steps/week (p<0.05,
paired t test vs week 0), and 4.66±0.18 additional METs/
week or 98±142 additional IPAQ MET-mins/week, respect-
ively, corresponding to non-signiﬁcant 10–30% increases
in weekly physical activity (p>0.05, paired t test vs week 0).
Biomolecular measurements: In study 1 participants, and
in the adherent group from study 2, CD36 and ABCA1
(which are positively regulated by exercise-associated sig-
nalling stimuli5 8 10 11) underwent signiﬁcant approxi-
mately twofold to threefold increases in expression
(p<0.05 in both cases; see table 1). Similarly, in study 3,
non-signiﬁcant 1.9-fold and 1.4-fold trends towards
increased expression were observed (p>0.05 in both
cases). Conversely, MMP-9 (which is negatively regulated
by exercise-associated signalling stimuli7) underwent
decreases in expression which either attained or neared
statistical signiﬁcance (p<0.01 for study 1 and the adher-
ent group from study 2; p=0.07 for study 3).
Vascular haemodynamic measurements: As expected, study
3 participants (who had been referred to NERS follow-
ing diagnosis of conditions that had raised CVD risk)
exhibited signiﬁcantly higher baseline readings with
regard to several vascular haemodynamic parameters
than did the healthy sedentary participants from the
other studies (see table 2). Nevertheless, in all three
studies, exercise participation was associated with signiﬁ-
cant reductions in peripheral BP (p<0.05; see table 1).
Arterial stiffness (as measured by AIx) decreased signiﬁ-
cantly in study 3 and the adherent group from study 2
(p<0.05 and <0.01, respectively), and a borderline-
signiﬁcant decrease (p=0.07) in aPWV was seen in study
3, but not in study 2.
Anthropometric and clinical measurements: Baseline BMI
data for all studies were in the ‘obese’ or ‘overweight’
range, which can be considered a cardiovascular risk
factor. Nevertheless, participants from study 3 (who had
been referred to NERS speciﬁcally because of diagnosis
with raised CVD risk) exhibited signiﬁcantly higher base-
line readings with regard to waist circumference
(p<0.01), circulating levels of glucose (p<0.001), total
cholesterol (p<0.01) and LDL-cholesterol (p<0.01) than
did the participants from the other studies (see table 2).
The most pronounced exercise-associated improve-
ments in beneﬁcial anthropometric and clinical para-
meters (ie, improvements in weight, BMI, waist
circumference, fasting insulin levels and insulin sensitiv-
ity) were seen in study 1. As study 1 involved the greatest
physical activity levels, this suggests that study 1’s inten-
sity reached the threshold required to achieve improve-
ments in these measures, but that of the other two
studies did not. Nevertheless, signiﬁcant reductions in
total cholesterol and LDL-cholesterol (p<0.01 and <0.05,
respectively), and borderline signiﬁcant improvements
in BMI and heart rate (p=0.07 and p=0.08, respectively),
were seen in study 3.
Correlative analyses: As shown in table 3, signiﬁcant posi-
tive associations between physical activity levels and
expression of CD36 or ABCA1, and signiﬁcant negative
associations between physical activity levels and MMP-9
expression, systolic BP or diastolic BP, or arterial stiffness,
were observed. ABCA1 expression correlated inversely
with fasting plasma glucose, while MMP-9 expression
correlated with systemic vascular haemodynamic mea-
sures (including systolic BP and AIx) and systemic mea-
sures of CVD risk (including fasting plasma levels of
total and LDL-cholesterol). Therefore, the current data
appear to support our previous proposals5–14 that
exercise-triggered cell signalling events which can be
detected in monocytes may contribute to mechanisms
that underpin systemic CVD risk-lowering health
beneﬁts.
DISCUSSION
Relevance to practice: The major conclusion of this investi-
gation is that cardiovascular health beneﬁts in line with
those seen in our previous investigations5–14 were
observed—albeit to slightly differing extents—in all
three studies. Study 1 participants underwent signiﬁcant
decreases in anthropometric measures such as BMI and
waist circumference, in vascular haemodynamic mea-
sures such as BP, and in clinical measures such as insulin
sensitivity (see table 1). The majority of these effects
were also seen in study 3 participants, and in members
of the adherent group within study 2; also, arterial stiff-
ness (which was not measured in study 1) underwent
decreases in both study 2 (decreased AIx (see table 1))
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Table 1 A comparison of ‘Δ-change’ (ie, week 8 vs week 0) measurements obtained from participants who completed three separate 8-week exercise programmes
(***p<0.001; **p<0.01;*p<0.05; (*)p<0.10, as detected via paired (ie, weeks 8 vs 0) t tests in each case)
Study 1 (n=22)
Study 2(n=65)
Study 3
(n=11)
Adherent gp;
n=32
Non-adherent
gp; n=33
Physical activity
Number of additional steps/week 30 000 8684±236*** NA 3486±469*
Number of/duration of sessions/week 3×45 min 2×34±3 min NA 2×35 min
METs per session 4.74 (or 14.22/
week)
3.58±0.06
(or 7.16/week)
NA 2.33±0.10
(or 4.66/week)
Δ IPAQ MET-min/week 540±0 296±29** −51±37 98±142
Anthropometric
Δ Mass (kg) −0.9±0.3*** 0.2±1.3 0±1.1 −0.5±0.4
Δ BMI (kg/m2) −0.4±0.1** 0±0.6 −0.3±0.4 −0.3±0.1(*)
Δ Waist circumference (cm) −5.5±1.1*** −0.8±2.6 −0.8±1.9 0±0.9
Biomolecular
CD36 (cf. week 0) 1.90±0.50* 1.88±0.21* 1.15±0.26 1.91±0.72
ABCA1 (cf. week 0) 1.95±0.31* 2.78±0.45* 1.47±0.46 1.37±0.40
MMP-9 (cf. week 0) 0.52±0.16** 0.69±0.08*** 1.14±0.10 0.64±0.21(*)
Vascular haemodynamic
Δ Systolic BP (mm Hg) −6.1±2.6* −6.0±9.0** −1.0±5.0 4.8±2.5
Δ Diastolic BP (mm Hg) −0.6±1.8 −3.0±6.0** 1.0±4.0 −4.1±1.3*
Δ Pulse pressure (mm Hg) −5.5±2.4* −3.0±9.0 −2.0±6.0 5.2±3.1
Δ Mean arterial pressure (mm Hg) −2.5±1.7(*) −4.0±6.0** 0±4.0 −2.6±1.7*
Δ Central systolic BP (mm Hg) (–) −5.0±7.0** 0±5.0 4.9±2.2
Δ Central diastolic BP (mm Hg) (–) −3.0±7.0** 2.0±3.0 −0.6±1.3
Δ Central pulse pressure (mm Hg) (–) −2.0±7.0 −1.0±5.0 5.4±2.8
Δ AIx at HR 75 bpm (%) (–) −4.0±6.0** 1.0±7.0 −3.0±0.4*
Δ MAP-adjusted carotid-femoral PWV (m/s) (–) 0.1±0.4 0.1±0.4 −0.3±0.2(*)
Δ HR (bpm) −2.2±2.9 −1.0±8.0 2.0±9.0 −6.8±2.9(*)
Clinical
Δ Triglycerides (mmol/L) 0.1±0.1 −0.1±0.4 −0.2±0.6 −0.1±0.1
Δ Total cholesterol (mmol/L) 0.3±0.4 −0.1±0.5 0.1±0.4 −0.4±0.1**
Δ HDL-cholesterol (mmol/L) 0.1±0.1 0.1±0.3 0±0.3 −0.1±0
Δ LDL-cholesterol (mmol/L) −0.1±0.2 −0.1±0.9 0.1±0.5 −0.4±0.1*
Δ Glucose (mmol/L) −0.1±0.1 0.1±0.5 0±0.2 −0.3±0.2
Δ Insulin (pmol/L) −16.2±9.6(*) −0.2±4.1 0.3±4.6 −2.8±2.3
Δ HOMA-IR (mmol/L, μU/mL) −0.6±0.3* 0±0.1 0±0.1 0.4±0.2
ABCA1, ATP-Binding Cassette protein A1; AIx, Augmentation Index; BMI, body mass index; BP, blood pressure; CD36, cluster of differentiation isoform-36; HDL, high-density lipoprotein;
HOMA,homoeostatic model assessment; HR, heart rate; IPAQ,International Physical Activity Questionnaire; LDL,low-density lipoprotein; MAP, mean arterial pressure; MMP-9, matrix
metalloproteinase-9; NA, not available; PWV, pulse wave velocity.
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and study 3 (decreased PWV (see table 1); this discrep-
ancy may be because study 3 participants were older, as
aPWV rather than AIx has been reported to be a more
sensitive measure of arterial stiffness in individuals of
age >55 years31). Interestingly, parameters for which
studies 2 and 3 did not achieve signiﬁcance included
body mass and waist circumference; this ability of studies
2 and 3 to achieve CVD risk-lowering beneﬁts without
impacting on body mass/waist circumference may be of
interest in itself, due to the widespread focus on weight
loss as a motivating factor with regard to promoting
engagement in physical activity initiatives.32
It should be noted that study 1 involved continuously
monitored sessions that took place under the constant
supervision of researchers. While this was possible within
a university setting, such an approach is not feasible in
community-based or exercise-referral programmes.
Importantly, studies 2 and 3 were undertaken on a
one-leader-per-group-of-participants basis, an approach
which has been reported to be suitable for increasing
public access to exercise.28 Therefore, the observation
that measureable health beneﬁts were achieved in
studies 2 and 3 supports the ‘translational’ value of
community-based/exercise-referral programmes.
However, studies 2 and 3 involved low levels of
adherence: ∼50% of study 2 participants, and >20% of
study 3 participants, did not adhere to their exer-
cise programmes. A commonly reported feature of
exercise-referral schemes is that only a minority of
patients engage fully, with one-third not attending any
appointments/sessions and only 37% completing their
programme.32 33 Previous NERS evaluations have
reported only marginally better engagement: 15% of
those referred by their GP to NERS did not attend, and
44% completed their exercise programme.18–21 While
NERS adherence levels were found to strongly inﬂuence
effectiveness in achieving increased physical activity
(OR=1.46, 95% CIs 1.17 to 1.84; p<0.05),19 previous
NERS evaluations did not then assess whether such
increased physical activity levels were associated with
decreases in CVD risk.
Importantly, the current study obtained data that can
address this deﬁciency, in that study 2’s adherent group
underwent numerous improvements in CVD risk-related
measures (see table 1) that were not seen in the non-
adherent group. Although exercise-referral specialists
use motivational interviewing techniques to attempt to
foster self-regulatory behaviour, patients who are
attempting to exert self-control in other aspects of their
lives may suffer resource depletion, which ultimately will
affect adherence.34 This has been identiﬁed as a factor
that may impact unfavourably on adherence to NERS
programmes,18 and the need for additional strategies to
enhance self-determination for exercise has been high-
lighted.34 35 The current study’s demonstration of
adherence-associated differences in impact suggest that
Table 2 Baseline data from participants in three separate 8-week exercise programmes (***p<0.001; **p<0.01; *p<0.05;
(*)p<0.10, as detected via one-way ANOVA with Tukey’s post hoc analysis in each case)
Study 1 (n=28) Study 2(n=65) Study 3 (n=14)
Anthropometric
Mass (kg) 78.2±13.4 75.8±2.2 86.6±6.2
BMI (kg/m2) 30.0±5.0 28.7±0.7 30.8±1.6
Waist circumference (cm) 93.4±14.0 87.1±1.8 101.9±4.7**
Age (years) 44.6±2.4 44.5±1.7 56.0±3.9**
Vascular haemodynamic
Systolic BP (mm Hg) 129.2±12.5 126.6±1.8 126.7±3.3
Diastolic BP (mm Hg) 78.1±8.8* 84.8±1.3 85.4±3.7
Pulse pressure (mm Hg) 47.4±2.0** 41.8±1.1 42.2±2.7
Mean arterial pressure (mm Hg) 95.2±7.8 98.7±11.3 99.6±8.7
Central systolic BP (mm Hg) (–) 112.9±1.6 116.7±4.2
Central diastolic BP (mm Hg) (–) 78.3±1.3 85.6±3.9*
Central pulse pressure (mm Hg) (–) 34.5±1.4 28.9±2.2*
AIx at HR 75 bpm (%) (–) 20.0±1.5 32.3±3.2(*)
MAP-adjusted carotid-femoral PWV (m/s) (–) 6.95±0.2 8.22±0.5**
HR (bpm) 80.0±11.4 66.2±1.3* 74.4±4.1
Clinical
Triglycerides (mmol/L) 1.4±0.1 1.0±0.1 1.4±0.1
Total cholesterol (mmol/L) 4.9±0.2 4.8±0.1 6.4±0.4**
HDL-cholesterol (mmol/L) 1.5±0.1 1.6±0.1 1.4±0.1
LDL-cholesterol (mmol/L) 2.8±0.2 2.8±0.1 4.4±0.3**
Glucose (mmol/L) 4.8±0.1 4.8±0.1 5.8±0.4***
Insulin (pmol/L) 52.4±12.0 31.0±15.5 52.2±10.7
HOMA-IR (mmol/L.μU/mL) 1.7±0.4 1.0±0.1 1.0±0.3
ANOVA, analysis of variance; AIx,Augmentation Index; BMI, body mass index; BP, blood pressure; HDL, high-density lipoprotein; HOMA,
homoeostatic model assessment; HR, heart rate; LDL,low-density lipoprotein; MAP, mean arterial pressure; PWV,pulse wave velocity.
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provision of biomarker feedback data to exercise-referral
patients may be of use in improving participants’ motiv-
ation to adhere to their recommended exercise
programmes.
Limitations: The research described in the current
manuscript has several limitations. First, the cohort sizes
are relatively small. Second, the studies were run on a
within-group basis, with baseline values (rather than a
separate control cohort) acting as comparators, rather
than the randomised control trial format used in previ-
ous NERS evaluations.18–21 However, our approach is
congruent with current National Institute for Health
and Care Excellence (NICE) guidelines36 and the NHS
Standard Evaluation Framework for physical activity
interventions,37 which cite investigation of whether primary
and secondary outcomes have changed over the course of the
intervention as appropriate practice. Finally, while the
three studies are broadly similar in design and aims,
they are not identical (eg, more involved haemodynamic
measurements such as AIx and aPWV were not carried
out in study 1). Nevertheless, despite these acknowl-
edged limitations, we hope that the current manuscript
is seen as making a valid contribution to the ongoing
debate with regard to implementation of exercise in clin-
ical and public health settings.18 20–23 34
CONCLUSIONS
The current manuscript presents evidence that the
majority of the exercise-associated effects on both bio-
markers and measurable health beneﬁts reported in our
previous laboratory-based studies5 6 8–12 are also
observed in participants exercising in community-based
and exercise-referral settings. Also, the CVD risk-
lowering beneﬁts seen in NERS participants with overt
CVD-related conditions were similar to those seen in
healthy cohorts (see studies 2 and 3, and our previous
studies5–14). These ﬁndings may be of use in guiding
policymakers with regard to the introduction and/or
continued implementation of community-based and
clinically associated exercise-referral programmes.
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